India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Mexico's Videgaray Concerned About Democracy in Venezuela
18:11 - Mexico Foreign Relations Minister Luis Videgaray discusses his concerns about democracy in Venezuela with Bloomberg's Erik Schatzker on "What'd You Miss?" (Source: Bloomberg)
  • Videgaray Says Mexico-U.S. Relations Go Beyond Trade
  • Trump Trade May Be on the Verge of a Reversal
  • Wall Street Frets Over Health Vote's Impact